Protein RPS19 for the treatment of inflammatory diseases and cancer
With respect to both structure and function, the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) is a unique mediator of the immune system, whose important role in inflammatory diseases such as septic shock, chronic inflammations and autoimmune diseases such as arthritis, glomerulonephritis, autoimmune encephalitis, and autoimmune diabetes is well known. In this context, the chemotactic effect of MIF on monocytes is an important step of the inflammatory cascade, which is mediated by a binding of MIF to the chemokine receptors CXCR2 and CXCR4.<br>
Our scientific studies now showed for the first time that the ribosomal protein S19 (symbol: RPS19, HGNC ID:10402) is able to inhibit the pro-inflammatory effect of the central mediator of inflammation, the macrophage migration inhibitory factor (MIF), in a receptordependent manner. Further in vitro experiments confirm an interaction of MIF with RPS19.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
